Sanofi
ROR GAMMA (RORy) MODULATORS
Last updated:
Abstract:
The present application relates to compounds according to (Formula IA) or (Formula IB): ##STR00001## or a pharmaceutically acceptable salt thereof. The compounds can be used as inhibitors of ROR.gamma. and are useful for the treatment of ROR.gamma. mediated diseases.
Status:
Application
Type:
Utility
Filling date:
11 Dec 2019
Issue date:
18 Jun 2020